Literature DB >> 32194146

Association of hsCRP and vitamin D levels with mild cognitive impairment in elderly type 2 diabetic patients.

Malgorzata Gorska-Ciebiada1, Maciej Ciebiada2.   

Abstract

AIMS: The aim of the study was to determine the serum levels of 25-hydroxyvitamin D and high-sensitivity C-reactive protein (hsCRP) in elderly diabetic patients with and without mild cognitive impairment (MCI) and to examine factors (including 25-hydroxyvitamin D and hsCRP) associated with MCI in elderly patients with type 2 diabetes (T2DM).
METHODS: A total of 194 T2DM elders were evaluated: 62 subjects with MCI and 132 controls. Data was collected concerning biochemical parameters and biomarkers.
RESULTS: HsCRP concentration was elevated and 25-hydroxyvitamin D level was decreased in MCI patients to controls. HsCRP level was negatively correlated with 25-hydroxyvitamin D level and with MoCA score, and highly correlated with HbA1c level. The multivariable analysis indicated that less years of formal education, previous CVD and hypertension, increased number of co-morbidities, higher level of hsCRP and lower level of 25-hydroxyvitamin D, are the predisposing factors for MCI.
CONCLUSIONS: Higher hsCRP level and lower 25-hydroxyvitamin D may be regarded as a state of cognitive impairment in elderly patients with T2DM. Further prospective larger studies should be conducted to check the association between decreased vitamin D and risk of cognitive decline and to clarify whether this association may be mediated by systemic inflammation.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  25-hydroxyvitamin D; Diabetes mellitus; Elderly; Mild cognitive impairment; hsCRP

Mesh:

Substances:

Year:  2020        PMID: 32194146     DOI: 10.1016/j.exger.2020.110926

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  2 in total

1.  Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient.

Authors:  Dandan Xu; Yue Yu; Yayun Xu; Jinfang Ge
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-10       Impact factor: 3.168

2.  Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study.

Authors:  Jichen Zhang; Jiancan Lu; Hongling Zhu; Xinglu Zhou; Xijuan Wei; Mingjun Gu
Journal:  Int J Endocrinol       Date:  2021-04-28       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.